CYPXF Financial Statements & Analysis
Complete financial statements for CYPXF including income statement, balance sheet, and cash flow statement. Analyze CYPXF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
2.5% ↑
Net Income
-56.6% ↓
Gross Margin
4.3% ↑
Operating Margin
32.0% ↑
Balance Sheet
Current Ratio
-35.2% ↓
Debt to Equity
61.1% ↓
Asset Turnover
39.8% ↑
Cash Flow
Operating Cash Flow
68.7% ↑
Net Cash Flow
-186.2% ↓
Free Cash Flow
182.6% ↑
Cash Flow to Debt
89.0% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 9.85M | 10.10M | 2.5% | |
| Gross Profit | 4.06M | 4.34M | 6.9% | |
| Operating Income | -1.67M | -1.17M | 30.3% | |
| Net Income | -897.00K | -1.41M | 56.6% | |
| EPS | -0.01 | -0.02 | 56.6% | |
| EBITDA | 41.00K | -514.00K | 1353.7% | |
| Gross Margin | 41.25% | 43.01% | 4.3% | |
| Operating Margin | -16.97% | -11.54% | 32.0% | |
| Net Income Margin | -9.11% | -13.91% | 52.7% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 10.10M | 9.85M | 9.96M | — | — |
| Gross Profit | 4.34M | 4.06M | 4.51M | — | — |
| Operating Income | -1.17M | -1.67M | -6.32M | — | — |
| Net Income | -1.41M | -897.00K | -5.90M | — | — |
| EPS | -0.02 | -0.01 | -0.09 | — | — |
| EBITDA | -514.00K | 41.00K | -4.92M | — | — |
| Gross Margin | 43.01% | 41.25% | 45.30% | — | — |
| Operating Margin | -11.54% | -16.97% | -63.43% | — | — |
| Net Income Margin | -13.91% | -9.11% | -59.24% | — | — |
| R&D Expenses | 0 | 0 | 100.00K | — | — |
Financial Metrics
Want to dive deeper into CYPXF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics